UnitedHealth Raises 2026 Profit Guidance as Medical Cost Management Improves

UnitedHealth reported first-quarter results that exceeded Wall Street expectations, prompting the company to raise its adjusted earnings per share forecast for 2026. The insurer now expects adjusted earnings to exceed $18.25 per share, an increase from its previous guidance of $17.75. This optimistic outlook is supported by a strategic turnaround plan led by a new management team. The strategy focuses on streamlining operations, investing heavily in artificial intelligence, and divesting the UK-based business of its Optum healthcare unit to restore profitability and corporate reputation. Financially, the company posted first-quarter net income of $6.28 billion, or $6.90 per share, with revenue climbing to $111.72 billion from $109.58 billion in the same period last year. Adjusted earnings for the quarter stood at $7.23 per share. A critical metric for the industry, the medical benefit ratio, came in at 83.9%. This figure represents a notable improvement over the 84.8% reported a year ago and significantly outperformed the 85.5% expected by analysts. The lower ratio indicates that the company is managing medical expenses more effectively relative to the premiums it collects. These results arrive as the broader insurance sector grapples with elevated costs from post-pandemic care surges and expensive specialty drugs. Furthermore, the company is positioned to benefit from a finalized 2027 Medicare Advantage payment rate increase from the Trump administration, which is expected to provide a tailwind for managed care organizations.